| Segment | Evaluation Parameter | Weightage |
|---|---|---|
| Core - Pharma Excellence | Strategic Relevance | 30% |
| Core - Pharma Excellence | Execution Excellence | 25% |
| Core - Pharma Excellence | Innovation & Differentiation | 25% |
| Core - Pharma Excellence | Measurable Impact | 20% |
| Manufacturing, Machinery & Ecosystem Excellence | Relevance to Pharma Manufacturing / Quality Need | 25% |
| Manufacturing, Machinery & Ecosystem Excellence | Technical Innovation & Differentiation | 25% |
| Manufacturing, Machinery & Ecosystem Excellence | Compliance, Safety & Reliability Impact | 20% |
| Manufacturing, Machinery & Ecosystem Excellence | Efficiency, Productivity or Cost Improvement | 15% |
| Manufacturing, Machinery & Ecosystem Excellence | Adoption, Scalability & Evidence of Performance | 15% |
| Market, Brand, Digital & Patient Access Excellence | Market / Patient Relevance | 25% |
| Market, Brand, Digital & Patient Access Excellence | Strategic Clarity | 25% |
| Market, Brand, Digital & Patient Access Excellence | Execution & Reach | 25% |
| Market, Brand, Digital & Patient Access Excellence | Measurable Impact | 25% |
| Institutional, Leadership & Emerging Enterprise | Sector Contribution | 30% |
| Institutional, Leadership & Emerging Enterprise | Leadership Credibility / Institutional Capability | 25% |
| Institutional, Leadership & Emerging Enterprise | Innovation & Problem Solving | 20% |
| Institutional, Leadership & Emerging Enterprise | Measurable Impact | 25% |
Platform: Microsoft Teams meeting
Meeting ID: 376 914 351 749 190
Passcode: Hr96AP98